World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
49
Citations
13927
World Ranking
5876
National Ranking
89

Best Publications

  • Overdependence on degraded gist memory in Alzheimer's disease.

    David A. Gallo;Kameron R. Shahid;Meredith A. Olson;Todd M. Solomon

  • Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

    D. Aarsland;K. Bronnick;C. Williams-Gray;D. Weintraub

  • Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment

    Javier Pagonabarraga;Jaime Kulisevsky;Antonio P Strafella;Antonio P Strafella;Paul Krack;Paul Krack

  • Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease.

    Javier Pagonabarraga;Jaime Kulisevsky;Gisela Llebaria;Carmen García-Sánchez

  • Cognitive impairment and dementia in Parkinson's disease.

    Javier Pagonabarraga;Jaime Kulisevsky;Jaime Kulisevsky

  • Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families.

    Laia Rodriguez-Revenga;Irene Madrigal;Javier Pagonabarraga;Mar Xunclà

  • Favorable Outcome of Ischemic Stroke in Patients Pretreated with Statins

    Joan Martí-Fàbregas;Meritxell Gomis;Adrià Arboix;Aitziber Aleu

  • Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia

    Jaime Kulisevsky;Javier Pagonabarraga;Berta Pascual‐Sedano;Carmen García‐Sánchez

  • Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase.

    Javier Pagonabarraga;Saul Martinez-Horta;Saul Martinez-Horta;Ramón Fernández de Bobadilla;Ramón Fernández de Bobadilla;Jesús Pérez

  • Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.

    Jaime Kulisevsky;Javier Pagonabarraga

  • Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes.

    Núria Setó-Salvia;Jordi Clarimón;Javier Pagonabarraga;Berta Pascual-Sedano

  • Pattern of Regional Cortical Thinning Associated with Cognitive Deterioration in Parkinson's Disease

    Javier Pagonabarraga;Idoia Corcuera-Solano;Yolanda Vives-Gilabert;Gisela Llebaria

  • Controlled study of decision-making and cognitive impairment in Parkinson's disease.

    Javier Pagonabarraga;Carmen García-Sánchez;Gisela Llebaria;Berta Pascual-Sedano Md

  • Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease

    Saul Martinez-Horta;Jesus Perez-Perez;Erik van Duijn;Ramon Fernandez-Bobadilla

  • Benefits of a prehospital stroke code system. Feasibility and efficacy in the first year of clinical practice in Barcelona, Spain.

    Belvís R;Cocho D;Martí-Fàbregas J;Pagonabarraga J

  • Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study.

    Maria C. Rodriguez-Oroz;Pablo Martínez Lage;Jose Sanchez-Mut;Isabel Lamet

  • Neural correlates of minor hallucinations in non-demented patients with Parkinson's disease.

    Javier Pagonabarraga;Carles Soriano-Mas;Gisela Llebaria;Marina López-Solà

  • Changes in artistic style and behaviour in Parkinson's disease: dopamine and creativity.

    Jaime Kulisevsky;Javier Pagonabarraga;Mercè Martinez-Corral

  • The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders.

    Daniel Alcolea;Jordi Clarimón;María Carmona-Iragui;Ignacio Illán-Gala

  • Minor hallucinations in Parkinson disease: A subtle symptom with major clinical implications.

    Abhishek Lenka;Javier Pagonabarraga;Pramod Kumar Pal;Helena Bejr-Kasem

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Recently Published Articles